Self-management of INR - a focus group study.

Background: Warfarin is a medication used in conditions with an increased risk of blood clots. Due to the potential for serious side effects, treatment must be closely monitored by measuring the International Normalised Ratio (INR). In some health trusts, Noklus (Norwegian Organization for Quality Improvement of Laboratory Examinations) offers training for patients in self-management of INR. The aim of this study was to explore Norwegian patients' experiences with self-management of INR and their motivations.

Material and method: In 2022, three focus group interviews were conducted at Nordland Hospital in Bodø, with a total of 16 individuals who performed self-management of INR. The interviews were audio-recorded, transcribed and analysed using systematic text condensation.

Results: Participants reported improved self-esteem and a sense of freedom after starting self-management of INR. Some expressed initial concerns about the increased responsibility for their own health, but they gradually developed a more relaxed attitude towards self-management. They also experienced reduced stress levels and gained increased knowledge about their own bodies. The training course enhanced participants' knowledge and confidence.

Interpretation: The study indicates that self-management of INR simplifies the daily life of patients and can have a positive impact on their quality of life.